Explore selected publications, evidence types, key findings, and registered studies with direct links to each primary record. This curated library is not a complete archive of the thousands of studies across the wider scientific literature.
5 publications
Showing records relevant to AC-KPV-NH2.
Key finding
The study reports that this study indicates tht KPV is transported into cells by PepT1 and might be a new therapeutic agent for IBD.
Gastroenterology 2008
Research relevant to AC-KPV-NH2. Relevant to AC-KPV-NH2
Key finding
The study reports that histologically, inflammatory infiltrates were significantly reduced in KPV-treated mice, which was confirmed by the significant reduction of MPO activity in colonic tissue after KPV treatment.
Inflammatory bowel diseases 2008
Research relevant to AC-KPV-NH2. Relevant to AC-KPV-NH2
Key finding
The study reports that notably, treatment with 50 μg/mL of KPV restored cell viability and reduced IL-1β secretion disrupted by PM10 exposure.
Tissue & cell 2025
Research relevant to AC-KPV-NH2. Relevant to AC-KPV-NH2
Key finding
The study reports that the anti-inflammatory properties of this peptide are also believed to be cyclic AMP dependent.
The Journal of investigative dermatology 2004
Research relevant to AC-KPV-NH2. Relevant to AC-KPV-NH2
Key finding
The study reports that alpha-melanocyte-stimulating hormone (alpha-MSH), a neuroimmunomodulatory peptide of ancient origin, is known to be involved in the control of host responses.
Annals of the New York Academy of Sciences 2000
Research relevant to AC-KPV-NH2. Relevant to AC-KPV-NH2
This library supports source-led professional evaluation. Product-specific clinical and regulatory guidance provides the framework for interpreting the records in context.
Browse all products